Trial design
NAFLD, Nonalcoholic Fatty Liver
NONALCOHOLIC FATTY LIVER
The Nonalcoholic Fatty Liver Disease-Intermittent Calorie Restriction trial was designed as a prospective, two-arm, open-label RCT to investigate the efficacy of 12-week ICR in reducing liver fat content in NAFLD patients.